All Conferences

Conference Proceedings: IC4E welcomes the submissions from on innovative work from researchers in work from researchers in academic, industry and government describing original research work in E-Education, E-Business, E-Management and E-Learning. Accepted excellent papers by IC4E 2024 will be published in the conference proccedings, which will be collected in the conference proceedings, and then indexed by Ei Compendex, and Scopus, etc. major databases. Journal Publication: Option 1: International Journal of Trade, Economics and Finance (IJTEF), which will be indexed by ProQuest, Crossref, Electronic Journals Library , EBSCO, and Ulrich's Periodicals Directory. ISSN: 2010-023X (Print) Frequency: Bimonthly DOI: 10.18178/IJTEF template: http://www.ic4e.net/IJTEF_template.doc…

Publication Information Submissions will be reviewed by the conference committees and accepted papers will be published in the following journals: 1. International Journal of Trade, Economics and Finance(IJTEF) ISSN: 2010-023X (Print) Frequency: Bimonthly DOI: 10.18178/IJTEF Abstracting/Indexing: ProQuest, Crossref, Electronic Journals Library, EBSCO, etc. 2. Journal of Economics, Business and Management (JOEBM) ISSN: 2301-3567 Frequency: Quarterly DOI: 10.18178/JOEBM Abstracting/Indexing: CNKI, Electronic Journals Library, Ulrich's Periodicals Directory, MESLibrary, Google Scholar, and Crossref. All submitted articles should report original, previously unpublished research results, experimental or theoretical, and will be peer-reviewed. Articles submitted to the journal should meet these criteria and must not be…

Publication: ICBCB 2024 papers will be published in ICBCB 2024 Conference Proceedings, which will be indexed by Ei Compendex and Scopus. Submission Methods: http://confsys.iconf.org/submission/icbcb2024 E-mail: [email protected]

Paper Publication: ICBEA 2024 papers will be published in International Conference Proceedings, indexed by Ei Compendex and Scopus. International Journal of Pharma Medicine and Biological Sciences (IJPMBS, ISSN: 2278-5221), which will be indexed by Embase, CNKI, ProQuest, etc. Excellent papers will be recommended to be submitted for publication in the International Journal-Molecular & Cellular Biomechanics (MCB, ISSN: 1556-5300) as a special issue paper, indexed by Scopus, Ei Compendex, BIOSIS Preview-Web of Science, INSPEC (IET), etc Electronic Submission System: http://confsys.iconf.org/submission/icbea2024 E-mail: [email protected]

The program will highlight the practice dilemmas and key management strategies essential to enhance the attendees' confidence in caring for heart failure patients. Program topics will provide details to ensure patients receive the highest, most-up-to-date quality of care and achieve the best possible outcomes. Learning Objectives -Recognize the spectrum of signs and symptoms suspicious for heart failure -Describe typical diagnostic testing essential for the diagnosis and management of patients with heart failure -Apply appropriate pharmacologic and non-pharmacologic strategies for patients across the spectrum of heart failure -Describe when referral for advanced heart failure therapies is indicated Intended Audience This course…

Optimising Logistics Support as a Force Enabler for the Central and Eastern European Region The SAE Media Group is pleased to present the 9th annual Defence Logistics Central and Eastern Europe Conference taking place on the 18 – 19 March in Prague, Czech Republic. As cooperation between armed forces, and the prevalence of joint logistics operations increases, the importance of defence logistics as a capability in its own right continues to grow. Join the Defence Logistics Central and Eastern Europe conference to get a detailed understanding of the new developments in defence supply chain sustainment, and strategies and take this…

We invite all participants worldwide to attend “11th International Conference on Gynecology and Obstetrics” scheduled on March 18-19, 2024 at Zurich, Switzerland. The 11th International Conference on Gynecology and Obstetrics brings together a one-of-a-kind and global blend of large and medium pharmaceutical, biotech, and analytic organisations, colleges, and clinical research establishments, making the gathering an ideal stage for sharing involvement, cultivating cross-industry and scholarly collaboration, and assessing developing innovations around the world. We hope to provide an ideal platform for Researchers, Scholars, and Key Speakers to share data and experiences, to empower people with their in-depth knowledge of Women's Health,…

Publication: The accepted and registered papers will be published in: International Journal of Information and Education Technology ISSN: 2010-3689 (Online) Abstracting/ Indexing: Scopus (CiteScore 2022: 2.0), INSPEC (IET), UGC-CARE List (India), CNKI, EBSCO, Google Scholar International Journal of Learning and Teaching ISSN: 2377-2891(Print); 2377-2905(Online) Abstracting/Indexing: Google Scholar; Crossref, CNKI, etc. Submission Methods: Full Paper(publication and oral presentation) Abstract(oral presentation only) Electronic Submission System (.pdf) http://confsys.iconf.org/submission/ielr2024

Join the big conversation as we take insurance innovation to the next level. Now in its 9th year, Insurance Innovators Nordics brings together a community of industry leaders and trailblazing innovators to network, learn, and define the future of the insurance industry. "An excellent opportunity to meet colleagues from across the industry." Chief Executive Officer, Storebrand Forsikring Check out this years key themes: Defining your strategic priorities Create a roadmap for 2024 and beyond, as the CEO of Gjensidige, the CCO Private Lines of Alm. Brand and more industry big hitters share their visions and reveal how they're turning risks…

The Innate Killer Summit is returning for the 9th year as the must-attend meeting for the NK community, committed to addressing the critical challenges across all NK-targeted therapeutic types. Join this focused, collaborative forum spanning Preclinical, Clinical Translation and CMC and Process development to brainstorm with industry pioneers on the best approaches to enhance efficacy and persistence as well as reduce the cost of production. Showcasing innovation across biopharma and academia, we have collaborated with MD Anderson, Replay Bio, Pfizer, Glycostem, Senti Bio, XNK Therapeutics, Sanofi, Zelluna Immunotherapy and many more to uncover translational lessons learned in liquid and solid…

Don't miss the Spatial Biology 2024! Join industry leaders, experts, and researchers for a 2-day event exploring the latest innovations in spatial research and technologies. Connect with global academic and research organisations, as well as pharma representatives, for high-level discussions on topics ranging from the application of spatial technologies in biology to spatial data analysis, spatial research in pharma R&D, and digital pathology for spatial biology. Mark your calendar to be part of this dynamic gathering!

The 7th Antigen-Specific Immune Tolerance Drug Development Summit returns as the definitive, industry-dedicated forum bringing you the latest discoveries, preclinical, proof-of-concept, biomarker, and clinical development on tolerogenic therapies. Immune tolerance approaches have unprecedented potential to not only treat autoimmune diseases but to cure them; resetting the immune system is the most advantageous approach in biopharma's arsenal to trailblaze past standard immunosuppression treatments and create a new era of transformative therapies. With Diamyd's phase III trial for type I diabetes, COUR, Anokion, Imcyse, Takeda, and Selecta's phase II trials all underway, the field is on the precipice of advancing efficacious antigen-specific…

Connecting leaders in drug discovery to optimise organ modelling techniques and facilitate advanced applications.

Optimising Logistics Support as a Force Enabler for the Central and Eastern European Region The SAE Media Group is pleased to present the 9th annual Defence Logistics Central and Eastern Europe Conference taking place on the 18 – 19 March in Prague, Czech Republic. As cooperation between armed forces, and the prevalence of joint logistics operations increases, the importance of defence logistics as a capability in its own right continues to grow. Join the Defence Logistics Central and Eastern Europe conference to get a detailed understanding of the new developments in defence supply chain sustainment, and strategies and take this…

The 6th Edition of International Conference on Materials Science and Engineering is a prestigious event that brings together researchers, scientists, engineers, industry professionals, and academicians from around the world. The 6th Edition of International Conference on Materials Science and Engineering (MATERIALS 2024), will be held in Singapore from March 18-20, 2024, in a hybrid format. Materials Science and Engineering Conference 2024 will focus on the theme of "Shaping Future by Combining Knowledge and Innovations in Material Science." Materials Congress 2024 aims to provide a platform for the exchange of ideas, the fostering of collaborations, and the sharing of cutting-edge research…

DFRWS is open to fresh insights that challenge the current boundaries of digital forensics. The submissions can cover a broad range of topics related to digital forensics, including, but not limited to: - Anti-forensics and anti-anti-forensics - AI-assisted digital forensics - Case studies and trend reports - Cloud and virtualized environment forensics - Covert channels (e.g. TOR, VPN) - Cryptocurrency investigation - Development of digital forensic infrastructures - Digital evidence sharing and exchange - Digital evidence and the law - Digital forensic preparedness/readiness - Digital investigation case management - Digital forensic tool validation - Digital forensic triage/survey - Event reconstruction…

The last 12 months have highlighted key milestones in European biopharma investment– from GSK injecting €1 million into a 15-building biotech campus in Stevenage, to AstraZeneca investing £1 billion into a new R AND D and Corporate HQ. As the pressure to expand and continue pipeline progression within a scattered and distributed market, there has never been a better time to know how to navigate unknown waters. Emulating the 2023 success, the Lab Asset and Facility Management in Pharma Europe returns for the second year running. This expert-led summit is solely dedicated to imparting expert knowledge with the goal of…

This event aims to gather automotive industry leaders, policymakers, and experts will have a platform to collaboratively devise strategies that prioritize cleaner mobility solutions, reduced carbon footprints, and enhanced environmental stewardship. As the world continues to grapple with the consequences of climate change, the automotive sector, being a significant contributor to carbon emissions, must take bold steps towards decarbonization. Many countries have also formulated requirements and policies for the development of low-carbon vehicles, and most companies in the automotive industry around the world have realized the importance of low-carbon development and sustainable development. Automotive industry players should make a comprehensive…

Advance More Personalized Therapies for Rare and Common Kidney Diseases The surge of clinical breakthroughs in SGLT2s, GLP-1s and ERAs for CKD, significant advancements to strengthen proteinuria and GFR slope as surrogates for long-term outcomes, and a wave of promising new targets in development, has truly lit the fuse on decades of innovative kidney research. Bringing together 200+ biopharma stakeholders, from scientific research to clinical development and outcomes, across three days of concentrated discussion, the 6th CKD Drug Development Summit is the definitive forum for KOLs, industry experts, and regulators to concentrate kidney innovation onto the next generation of drug…

Determining MoA and Satisfying Regulatory Requirements In the dynamic cell therapy landscape, the challenge of potency assay development looms large, as exemplified by clinical holds experienced by Mesoblast and Verve Therapeutics in recent years. With unclear licensing standards and the surge in cell therapy products advancing through phase development, linking mechanisms of action to potency assays scientifically has become a pressing concern. At the 3rd Cell Therapy Potency Assay Summit, we bring together over 120 analytical, quality control, and regulatory experts to address these pressing concerns. Our goal is to collaboratively design more effective potency assays that not only streamline…